Blocking these TLR drivers is expected to disrupt the pathological re-enforcing cycle of inflammation and neurodegeneration leading to slowing of disease progression and improvement of symptoms. Eos ...

Researchers from King's College London, in collaboration with academics from Imperial College London, are exploring whether ...

Covid-19 changed the global approach to prophylactic trials, many of which can benefit from adaptive designs, says the report ...

The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to ...

A burgeoning number of studies are examining pediatric health equity, diversity, and inclusion (EDI). But if not done right, ...

The Eastpark Medical Center, that’s been in the works since 2017, has officially opened its doors to patients.The center ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with Solu Therapeutics (Solu) and is pleased to announce the ...

The presumptive new CDC director, Dave Weldon, is a known vaccine safety skeptic. In contrast, the FDA choice — Johns Hopkins ...

MDCX READ THE FULL V.MDCX RESEARCH REPORT IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq On ...

In 2021, a research team discovered the insulin-inhibitory receptor ... "Our goal is to pave the way for clinical trials and thereby contribute to the treatment, and hopefully even the cure, of ...

However, research in Ukraine has been undeniably affected. A stark example of this has been a dramatic fall-off in clinical trials. Before the start of the full-scale invasion, Ukraine's clinical ...

PRO’s. Keep this acronym in mind: it stands for Patient Reported Outcomes. And in practice it highlights the importance of ...